However, amplification and/or overexpression of the HER2 oncogene, which belongs to the epidermal growth factor receptor (EGFR/HER) family, occurs in about 15% of invasive BCs, and is associated with increased cell proliferation and motility, increased angiogenesis, tumor invasiveness, and decreased apoptosis [34–35]. Here, EGFR is linked to neoplasm.